Back to list

Transcarent

Developer of consumer-directed health and care platform intended to facilitate improved outcomes and cost-effective deci
Clinics/Outpatient Services 📍 Denver, CO Founded 2020
Current Valuation
$2.7B
as of 2025-Q2
UNICORN
Developer of consumer-directed health and care platform intended to facilitate improved outcomes and cost-effective decisions.

Company Profile

Founded
2020
HQ
Denver, CO
Employees
454
Total Raised
$905M
Last Round
Series D1 — $200M (Apr 2025)
IPO Status
private

Fundraising Status

Series D1 · $200M · 1y 4mo ago
privateTotal raised $905M

Secondary Market

Implied price / share
$10.38
Last round price / share
$20.48
vs last round
-49.3%
Last round price vs secondary price
Last round vs current secondary price per share$20.48Last round$10.38Current
Secondary price return by period
Secondary market period returns3-month0.0%6-month+2.7%1-year-28.2%All-time-45.4%
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Series D1$200MApr 2025$2.7B
Health CarePersonal HealthSoftware
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2025-Q2. Refreshed quarterly.